Objective. To assess the occurrence of adverse events in a cohort of patients with polymyalgia
rheumatica (PMR), treated with low-dose glucocorticoids (GC). Methods. This was a …

OBJECTIVE: To analyze the influence of low dose methotrexate (MTX) on bone using data
from a large multicenter, cross-sectional study on bone mineral density (BMD) in women with …

Objective. To assess the prevalence of comorbidity in a cohort of patients with rheumatoid
arthritis (RA), treated or not with low-dose glucocorticoids (GC) and who have been followed …

Osteoporosis is a generalised bone disease characterised by decreased bone mass and
deterioration of bone microarchitecture predisposing to fragility fractures. Bone fractures are a …

Purpose Tumor induced osteomalacia (TIO) is a rare disease of mineral metabolism, whose
clinical picture is dominated by hypophosphatemia usually due to an excess of circulating …

Osteoporosis (OP) is a silent disease unless a fracture occurs; it is a major health problem,
mainly due to fragility fractures, that occur at vertebral and peripheral sites. Vertebral fractures …

Osteoporosis is a prevalent bone disease with a relevant burden of mortality and comorbidity,
especially due to fragility fractures occurring as a result of reduced bone mineral density. …

Pregnancy and lactation-associated osteoporosis (PAO) is a rare condition characterized by
the occurrence of fragility fractures, most commonly vertebral, in late pregnancy or the early …

Aims: The aim of this study was to assess the effects of a single infusion of the bisphosphonate
neridronate (N) on parameters of inflammation and bone resorption in rheumatoid …

Purpose LRP5 high bone mass (HBM) is an autosomal dominant endosteal hyperostosis
caused by mutations of the low-density lipoprotein receptor-related protein 5 (LRP5) gene. …